{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:56:37Z","timestamp":1790355397885,"version":"4.1.0"},"reference-count":196,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1124\/pharmrev.123.001028","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T16:55:13Z","timestamp":1718211313000},"page":"896-914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["The Art of Finding the Right Drug Target: Emerging Methods and Strategies"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3749-7201","authenticated-orcid":false,"given":"Zi-Chang","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6565-6372","authenticated-orcid":false,"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6904-1271","authenticated-orcid":false,"given":"Yi-Kun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9829-4833","authenticated-orcid":false,"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3729-5669","authenticated-orcid":false,"given":"Debatosh","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4538-5533","authenticated-orcid":false,"given":"Mo-Xian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9173-6608","authenticated-orcid":false,"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pharmrev.123.001028_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/07391102.2023.2199081","article-title":"Discovery of potent DNMT1 inhibitors against sickle cell disease using structural-based virtual screening, MM-GBSA and molecular dynamics simulation-based approaches","volume":"42","author":"Ala","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"10.1124\/pharmrev.123.001028_bib2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41587-022-01520-x","article-title":"Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models","volume":"41","author":"Alles\u00f8e","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1124\/pharmrev.123.001028_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154231","article-title":"Synergistic antitumor effects of compound-composed optimal formula from Aidi injection on hepatocellular carcinoma and colorectal cancer","volume":"103","author":"An","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1124\/pharmrev.123.001028_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab275","article-title":"A heterogeneous network embedding framework for predicting similarity-based drug-target interactions","volume":"22","author":"An","year":"2021","journal-title":"Brief Bioinform"},{"key":"10.1124\/pharmrev.123.001028_bib5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ccell.2015.10.002","article-title":"Targeting the AAA ATPase p97 as an approach to treat cancer through disruption of protein homeostasis","volume":"28","author":"Anderson","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1124\/pharmrev.123.001028_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.tibs.2019.04.004","article-title":"Drug-target association kinetics in drug discovery","volume":"44","author":"Ap","year":"2019","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/pharmrev.123.001028_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab120","article-title":"Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19","volume":"22","author":"Auwul","year":"2021","journal-title":"Brief Bioinform"},{"key":"10.1124\/pharmrev.123.001028_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108163","article-title":"The discovery of inhibitors of the SARS-CoV-2 S protein through computational drug repurposing","volume":"171","author":"Avil\u00e9s-Al\u00eda","year":"2024","journal-title":"Comput Biol Med"},{"key":"10.1124\/pharmrev.123.001028_bib9","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3390\/molecules28041663","article-title":"Comparative studies on resampling techniques in machine learning and deep learning models for drug-target interaction prediction","volume":"28","author":"Azlim Khan","year":"2023","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.123.001028_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/bib\/bbz157","article-title":"Machine learning approaches and databases for prediction of drug-target interaction: a survey paper","volume":"22","author":"Bagherian","year":"2021","journal-title":"Brief Bioinform"},{"key":"10.1124\/pharmrev.123.001028_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkp335","article-title":"MEME SUITE: tools for motif discovery and searching","volume":"37","author":"Bailey","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pharmrev.123.001028_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114895","article-title":"The potential value of amlexanox in the treatment of cancer: molecular targets and therapeutic perspectives","volume":"197","author":"Bailly","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.123.001028_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s42003-020-0795-6","article-title":"An isothermal shift assay for proteome scale drug-target identification","volume":"3","author":"Ball","year":"2020","journal-title":"Commun Biol"},{"key":"10.1124\/pharmrev.123.001028_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108676","article-title":"Genome-wide CRISPR-Cas9 knockout library screening identified PTPMT1 in cardiolipin synthesis is crucial to survival in hypoxia in liver cancer","volume":"34","author":"Bao","year":"2021","journal-title":"Cell Rep"},{"key":"10.1124\/pharmrev.123.001028_bib15","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/nchembio.2473","article-title":"Target class drug discovery","volume":"13","author":"Barnash","year":"2017","journal-title":"Nat Chem Biol"},{"key":"10.1124\/pharmrev.123.001028_bib16","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3390\/biomedicines9101302","article-title":"The NMD pathway regulates GABARAPL1 mRNA during the EMT","volume":"9","author":"Baudu","year":"2021","journal-title":"Biomedicines"},{"key":"10.1124\/pharmrev.123.001028_bib17","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0140-6736(20)30164-1","article-title":"Small molecules, big impact: 20 years of targeted therapy in oncology","volume":"395","author":"Bedard","year":"2020","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.123.001028_bib18","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3390\/ijms21031085","article-title":"Dbp5\/DDX19 between translational readthrough and nonsense mediated decay","volume":"21","author":"Bei\u00dfel","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.123.001028_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2020.10.022","article-title":"Zmat3 is a key splicing regulator in the p53 tumor suppression program","volume":"80","author":"Bieging-Rolett","year":"2020","journal-title":"Mol Cell"},{"key":"10.1124\/pharmrev.123.001028_bib20","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.drudis.2020.07.024","article-title":"High-throughput screening: today's biochemical and cell-based approaches","volume":"25","author":"Blay","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1124\/pharmrev.123.001028_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112642","article-title":"Compromised nonsense-mediated RNA decay results in truncated RNA-binding protein production upon DUX4 expression","volume":"42","author":"Campbell","year":"2023","journal-title":"Cell Rep"},{"key":"10.1124\/pharmrev.123.001028_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ddtec.2018.01.001","article-title":"The multiplexed CRISPR targeting platforms","volume":"28","author":"Cao","year":"2018","journal-title":"Drug Discov Today Technol"},{"key":"10.1124\/pharmrev.123.001028_bib23","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41375-022-01518-z","article-title":"Multi-omics reveals mitochondrial metabolism proteins susceptible for drug discovery in AML","volume":"36","author":"Caplan","year":"2022","journal-title":"Leukemia"},{"key":"10.1124\/pharmrev.123.001028_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13252","article-title":"Neuropathological stage-dependent proteome mapping of the olfactory tract in Alzheimer's disease: from early olfactory-related omics signatures to computational repurposing of drug candidates","author":"Cartas-Cejudo","year":"2024","journal-title":"Brain Pathol"},{"key":"10.1124\/pharmrev.123.001028_bib25","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1073\/pnas.1820799116","article-title":"From single drug targets to synergistic network pharmacology in ischemic stroke","volume":"116","author":"Casas","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pharmrev.123.001028_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btac463","article-title":"Improved NSGA-II algorithms for multi-objective biomarker discovery","volume":"38","author":"Cattelani","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1124\/pharmrev.123.001028_bib27","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.7150\/thno.71144","article-title":"CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives","volume":"12","author":"Chan","year":"2022","journal-title":"Theranostics"},{"key":"10.1124\/pharmrev.123.001028_bib28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/biomedicines8090320","article-title":"Investigating core signaling pathways of hepatitis B virus pathogenesis for biomarkers identification and drug discovery via systems biology and deep learning method","volume":"8","author":"Chang","year":"2020","journal-title":"Biomedicines"},{"key":"10.1124\/pharmrev.123.001028_bib29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s12967-023-04293-2","article-title":"Pharmacological inhibition of demethylzeylasteral on JAK-STAT signaling ameliorates vitiligo","volume":"21","author":"Chang","year":"2023","journal-title":"J Transl Med"},{"key":"10.1124\/pharmrev.123.001028_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12974-022-02682-w","article-title":"Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases","volume":"19","author":"Chen","year":"2022","journal-title":"J Neuroinflammation"},{"key":"10.1124\/pharmrev.123.001028_bib31","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1109\/TCBB.2022.3153963","article-title":"Predicting drug-target interaction via self-supervised learning","volume":"20","author":"Chen","year":"2022","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform Pp"},{"key":"10.1124\/pharmrev.123.001028_bib32","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.3390\/molecules23092208","article-title":"Machine learning for drug-target interaction prediction","volume":"23","author":"Chen","year":"2018","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.123.001028_bib33","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/bib\/bbv066","article-title":"Drug-target interaction prediction: databases, web servers and computational models","volume":"17","author":"Chen","year":"2016","journal-title":"Brief Bioinform"},{"key":"10.1124\/pharmrev.123.001028_bib34","article-title":"HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma","volume":"11","author":"Chen","year":"2023","journal-title":"PeerJ"},{"key":"10.1124\/pharmrev.123.001028_bib35","doi-asserted-by":"crossref","DOI":"10.1242\/dev.200764","article-title":"Progression of the pluripotent epiblast depends upon the NMD factor UPF2","volume":"149","author":"Chousal","year":"2022","journal-title":"Development"},{"key":"10.1124\/pharmrev.123.001028_bib36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-022-02350-0","article-title":"Targeting selenoprotein H in the nucleolus suppresses tumors and metastases by Isovalerylspiramycin I","volume":"41","author":"Cui","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1124\/pharmrev.123.001028_bib37","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/17460441.2016.1195365","article-title":"Applied metabolomics in drug discovery","volume":"11","author":"Cuperlovic-Culf","year":"2016","journal-title":"Expert Opin Drug Discov"},{"key":"10.1124\/pharmrev.123.001028_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2199-12-30","article-title":"TRPC1 transcript variants, inefficient nonsense-mediated decay and low up-frameshift-1 in vascular smooth muscle cells","volume":"12","author":"Dedman","year":"2011","journal-title":"BMC Mol Biol"},{"key":"10.1124\/pharmrev.123.001028_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1561\/2000000039","article-title":"Deep Learning: Methods and Applications","volume":"7","author":"Deng","year":"2014","journal-title":"Foundations and Trends in Signal Processing"},{"key":"10.1124\/pharmrev.123.001028_bib40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1568009614666140411101942","article-title":"Target identification of grape seed extract in colorectal cancer using drug affinity responsive target stability (DARTS) technique: role of endoplasmic reticulum stress response proteins","volume":"14","author":"Derry","year":"2014","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1124\/pharmrev.123.001028_bib41","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.3390\/cells11193045","article-title":"Recent progress and future prospect of CRISPR\/Cas-derived transcription activation (CRISPRa) system in plants","volume":"11","author":"Ding","year":"2022","journal-title":"Cells"},{"key":"10.1124\/pharmrev.123.001028_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.07.044","article-title":"Systematic immunotherapy target discovery using genome-scale in vivo CRISPR screens in CD8 T cells","volume":"178","author":"Dong","year":"2019","journal-title":"Cell"},{"key":"10.1124\/pharmrev.123.001028_bib43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/B978-0-12-420119-4.00009-4","article-title":"Gel filtration chromatography (size exclusion chromatography) of proteins","volume":"541","author":"Duong-Ly","year":"2014","journal-title":"Methods Enzymol"},{"key":"10.1124\/pharmrev.123.001028_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2217\/fon-2023-0560","article-title":"Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary","volume":"20","author":"Dy","year":"2023","journal-title":"Future Oncol"},{"key":"10.1124\/pharmrev.123.001028_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102592","article-title":"Features and factors that dictate if terminating ribosomes cause or counteract nonsense-mediated mRNA decay","volume":"298","author":"Embree","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.123.001028_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13195-021-00951-z","article-title":"Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease","volume":"14","author":"Fang","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"10.1124\/pharmrev.123.001028_bib47","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1134\/S0006297922090103","article-title":"Mass spectrometry-based chemical proteomics for drug target discoveries","volume":"87","author":"Fedorov","year":"2022","journal-title":"Biochemistry (Mosc)"},{"key":"10.1124\/pharmrev.123.001028_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.964295","article-title":"Drug affinity-responsive target stability unveils filamins as biological targets for artemetin, an anti-cancer flavonoid","volume":"9","author":"Ferraro","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1124\/pharmrev.123.001028_bib49","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/hmg\/8.10.1893","article-title":"Nonsense-mediated mRNA decay in health and disease","volume":"8","author":"Frischmeyer","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1124\/pharmrev.123.001028_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100934","article-title":"Mapping cryptic binding sites of drug targets to overcome drug resistance","volume":"67","author":"Gao","year":"2023","journal-title":"Drug Resist Updat"},{"key":"10.1124\/pharmrev.123.001028_bib51","doi-asserted-by":"crossref","DOI":"10.15252\/msb.202210914","article-title":"Metabolomics paves the way for improved drug target identification","volume":"18","author":"Garana","year":"2022","journal-title":"Mol Syst Biol"},{"key":"10.1124\/pharmrev.123.001028_bib52","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.drudis.2011.09.007","article-title":"What makes a good drug target?","volume":"16","author":"Gashaw","year":"2011","journal-title":"Drug Discov Today"},{"key":"10.1124\/pharmrev.123.001028_bib53","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.biopsych.2022.11.002","article-title":"Prioritization of drug targets for neurodegenerative diseases by integrating genetic and proteomic data from brain and blood","volume":"93","author":"Ge","year":"2023","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pharmrev.123.001028_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1359147","article-title":"Proinflammatory cytokines suppress nonsense-mediated RNA decay to impair regulated transcript isoform processing in pancreatic \u03b2-cells","volume":"15","author":"Ghiasi","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1124\/pharmrev.123.001028_bib55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/17460441.2022.1991306","article-title":"High-throughput screening for drug discovery targeting the cancer cell-microenvironment interactions in hematological cancers","volume":"17","author":"Giri","year":"2022","journal-title":"Expert Opin Drug Discov"},{"key":"10.1124\/pharmrev.123.001028_bib56","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2174\/1389450120666181204164721","article-title":"Understanding membrane protein drug targets in computational perspective","volume":"20","author":"Gong","year":"2019","journal-title":"Curr Drug Targets"},{"key":"10.1124\/pharmrev.123.001028_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110460","article-title":"Proteome-centric cross-omics characterization and integrated network analyses of triple-negative breast cancer","volume":"38","author":"Gong","year":"2022","journal-title":"Cell Rep"},{"key":"10.1124\/pharmrev.123.001028_bib58","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1158\/1078-0432.CCR-23-2975","article-title":"Selective CDK7 inhibition suppresses cell cycle progression and MYC signaling while enhancing apoptosis in therapy-resistant estrogen receptor positive breast cancer","volume":"30","author":"Guarducci","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1124\/pharmrev.123.001028_bib59","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","article-title":"Artificial intelligence to deep learning: machine intelligence approach for drug discovery","volume":"25","author":"Gupta","year":"2021","journal-title":"Mol Divers"},{"key":"10.1124\/pharmrev.123.001028_bib60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ccell.2020.04.006","article-title":"Functional genomics for cancer drug target discovery","volume":"38","author":"Haley","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1124\/pharmrev.123.001028_bib61","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nbt.3834","article-title":"Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions","volume":"35","author":"Han","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1124\/pharmrev.123.001028_bib62","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13075-021-02619-3","article-title":"Isopsoralen ameliorates rheumatoid arthritis by targeting MIF","volume":"23","author":"Han","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1124\/pharmrev.123.001028_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110963","article-title":"BNTA attenuates temporomandibular joint osteoarthritis progression by directly targeting ALDH3A1: an in vivo and in vitro study","volume":"124","author":"He","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/pharmrev.123.001028_bib64","first-page":"295","article-title":"Perspective of signal processing-based on brain-computer interfaces using machine learning methods","volume":"308","author":"He","year":"2023","journal-title":"Stud Health Technol Inform"},{"key":"10.1124\/pharmrev.123.001028_bib65","doi-asserted-by":"crossref","DOI":"10.15252\/msb.202110767","article-title":"High-throughput metabolomics predicts drug-target relationships for eukaryotic proteins","volume":"18","author":"Holbrook-Smith","year":"2022","journal-title":"Mol Syst Biol"},{"key":"10.1124\/pharmrev.123.001028_bib66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1124\/pharmrev.123.001028_bib67","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1007\/s11033-022-07211-9","article-title":"The edited UPF1 is correlated with elevated asparagine synthetase in pancreatic ductal adenocarcinomas","volume":"49","author":"Hu","year":"2022","journal-title":"Mol Biol Rep"},{"key":"10.1124\/pharmrev.123.001028_bib68","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-0716-0954-5_15","article-title":"Drug affinity responsive target stability (DARTS) assay to detect interaction between a purified protein and a small molecule","volume":"2213","author":"Huang","year":"2021","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pharmrev.123.001028_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002234","article-title":"Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection","volume":"7","author":"Huang","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1124\/pharmrev.123.001028_bib70","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3390\/cancers12030543","article-title":"Autophagic inhibition via lysosomal integrity dysfunction leads to antitumor activity in glioma treatment","volume":"12","author":"Hwang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1124\/pharmrev.123.001028_bib71","article-title":"Profiling the protein targets of unmodified bio-active molecules with drug affinity responsive target stability and liquid chromatography\/tandem mass spectrometry","volume":"20","author":"Hwang","year":"2020","journal-title":"Proteomics"},{"key":"10.1124\/pharmrev.123.001028_bib72","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1080\/15548627.2020.1841953","article-title":"Antidepressant drug sertraline modulates AMPK-MTOR signaling-mediated autophagy via targeting mitochondrial VDAC1 protein","volume":"17","author":"Hwang","year":"2021","journal-title":"Autophagy"},{"key":"10.1124\/pharmrev.123.001028_bib73","article-title":"Current advances in comprehensive omics data mining for oncology and cancer research","volume":"1879","author":"Jeong","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1124\/pharmrev.123.001028_bib74","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3390\/molecules28031329","article-title":"Discovery, validation, and target prediction of antibacterial and antidiabetic components of archidendron clypearia based on a combination of multiple analytical methods","volume":"28","author":"Ji","year":"2023","journal-title":"Molecules"},{"key":"10.1124\/pharmrev.123.001028_bib75","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41573-022-00615-z","article-title":"Rational combinations of targeted cancer therapies: background, advances and challenges","volume":"22","author":"Jin","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pharmrev.123.001028_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2017.09.012","article-title":"Combined CRISPRi\/a-based chemical genetic screens reveal that rigosertib is a microtubule-destabilizing agent","volume":"68","author":"Jost","year":"2017","journal-title":"Mol Cell"},{"key":"10.1124\/pharmrev.123.001028_bib77","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymeth.2021.10.007","article-title":"Comparative analysis of network-based approaches and machine learning algorithms for predicting drug-target interactions","volume":"198","author":"Jung","year":"2022","journal-title":"Methods"},{"key":"10.1124\/pharmrev.123.001028_bib78","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a032862","article-title":"Nonsense-mediated mRNA decay begins where translation ends","volume":"11","author":"Karousis","year":"2019","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1124\/pharmrev.123.001028_bib79","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.3390\/ijms21072493","article-title":"A precision strategy to cure renal cell carcinoma by targeting transglutaminase 2","volume":"21","author":"Kim","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1124\/pharmrev.123.001028_bib80","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/s41587-021-00938-z","article-title":"Efficient C\u00b7G-to-G\u00b7C base editors developed using CRISPRi screens, target-library analysis, and machine learning","volume":"39","author":"Koblan","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1124\/pharmrev.123.001028_bib81","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41573-021-00268-4","article-title":"Advances in TRP channel drug discovery: from target validation to clinical studies","volume":"21","author":"Koivisto","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pharmrev.123.001028_bib82","article-title":"A system of reporters for comparative investigation of EJC-independent and EJC-enhanced nonsense-mediated mRNA decay","volume":"52","author":"Kolakada","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/pharmrev.123.001028_bib83","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s12551-022-01028-3","article-title":"Protein binding sites for drug design","volume":"14","author":"Konc","year":"2022","journal-title":"Biophys Rev"},{"key":"10.1124\/pharmrev.123.001028_bib84","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10142-023-01280-0","article-title":"MyeloDB: a multi-omics resource for multiple myeloma","volume":"24","author":"Kumar","year":"2024","journal-title":"Funct Integr Genomics"},{"key":"10.1124\/pharmrev.123.001028_bib85","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s10038-017-0376-9","article-title":"CRISPR\/Cas9 library screening for drug target discovery","volume":"63","author":"Kurata","year":"2018","journal-title":"J Hum Genet"},{"key":"10.1124\/pharmrev.123.001028_bib86","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41556-020-00618-1","article-title":"Loss of the fragile X syndrome protein FMRP results in misregulation of nonsense-mediated mRNA decay","volume":"23","author":"Kurosaki","year":"2021","journal-title":"Nat Cell Biol"},{"key":"10.1124\/pharmrev.123.001028_bib87","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/1878-0261.13343","article-title":"SMG1, a nonsense-mediated mRNA decay (NMD) regulator, as a candidate therapeutic target in multiple myeloma","volume":"17","author":"Leeksma","year":"2023","journal-title":"Mol Oncol"},{"key":"10.1124\/pharmrev.123.001028_bib88","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41419-021-04027-6","article-title":"CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer","volume":"12","author":"Lei","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1124\/pharmrev.123.001028_bib89","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/2159-8290.CD-19-0780","article-title":"In vivo epigenetic CRISPR screen identifies asf1a as an immunotherapeutic target in kras-mutant lung adenocarcinoma","volume":"10","author":"Li","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1124\/pharmrev.123.001028_bib90","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1158\/0008-5472.CAN-18-2868","article-title":"N(6)-methyladenosine modulates nonsense-mediated mRNA decay in human glioblastoma","volume":"79","author":"Li","year":"2019","journal-title":"Cancer Res"},{"key":"10.1124\/pharmrev.123.001028_bib91","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1093\/bioinformatics\/btac377","article-title":"Effective drug-target interaction prediction with mutual interaction neural network","volume":"38","author":"Li","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1124\/pharmrev.123.001028_bib92","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1389450120666190923162203","article-title":"Bioinformatics approaches for anti-cancer drug discovery","volume":"21","author":"Li","year":"2020","journal-title":"Curr Drug Targets"},{"key":"10.1124\/pharmrev.123.001028_bib93","article-title":"LINC02561 promotes metastasis in HCC via HIF1-\u03b1\/NDRG1\/UPF1 axis","volume":"896","author":"Li","year":"2023","journal-title":"Gene"},{"key":"10.1124\/pharmrev.123.001028_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202100320","article-title":"Proteome and secretome analysis of pancreatic cancer cells","volume":"22","author":"Li","year":"2022","journal-title":"Proteomics"},{"key":"10.1124\/pharmrev.123.001028_bib95","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41392-021-00508-4","article-title":"Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1124\/pharmrev.123.001028_bib96","article-title":"Drug-target interaction predication via multi-channel graph neural networks","volume":"23","author":"Li","year":"2022","journal-title":"Brief Bioinform"},{"key":"10.1124\/pharmrev.123.001028_bib97","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1261\/rna.058040.116","article-title":"Inhibition of nonsense-mediated RNA decay by ER stress","volume":"23","author":"Li","year":"2017","journal-title":"RNA"},{"key":"10.1124\/pharmrev.123.001028_bib98","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac353","article-title":"Multiple similarity drug-target interaction prediction with random walks and matrix factorization","volume":"23","author":"Liu","year":"2022","journal-title":"Brief Bioinform"},{"key":"10.1124\/pharmrev.123.001028_bib99","article-title":"Facing inevitable PARPis resistance: mechanisms and therapeutic strategies for breast cancer treatment","volume":"1","author":"Liu","year":"2023","journal-title":"Interdiscip Med"},{"key":"10.1124\/pharmrev.123.001028_bib100","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1038\/s41467-022-31155-0","article-title":"The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors","volume":"13","author":"Liu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.123.001028_bib101","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.3390\/cells9081888","article-title":"Therapeutic target discovery using high-throughput genetic screens in acute myeloid leukemia","volume":"9","author":"Liu","year":"2020","journal-title":"Cells"},{"key":"10.1124\/pharmrev.123.001028_bib102","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s44307-024-00009-9","article-title":"Importance of pre-mRNA splicing and its study tools in plants","volume":"2","author":"Liu","year":"2024","journal-title":"Adv Biotechnol"},{"key":"10.1124\/pharmrev.123.001028_bib103","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1073\/pnas.0910040106","article-title":"Target identification using drug affinity responsive target stability (DARTS)","volume":"106","author":"Lomenick","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pharmrev.123.001028_bib104","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jare.2020.09.001","article-title":"Iminostilbene, a novel small-molecule modulator of PKM2, suppresses macrophage inflammation in myocardial ischemia-reperfusion injury","volume":"29","author":"Lu","year":"2021","journal-title":"J Adv Res"},{"key":"10.1124\/pharmrev.123.001028_bib105","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/med.21993","article-title":"Progress in RAS-targeted therapeutic strategies: from small molecule inhibitors to proteolysis targeting chimeras","volume":"44","author":"Lu","year":"2023","journal-title":"Med Res Rev"},{"key":"10.1124\/pharmrev.123.001028_bib106","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12859-019-2730-8","article-title":"Screening drug target combinations in disease-related molecular networks","volume":"20","author":"Luo","year":"2019","journal-title":"BMC Bioinformatics"},{"key":"10.1124\/pharmrev.123.001028_bib107","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.omto.2021.12.025","article-title":"Narciclasine targets STAT3 via distinct mechanisms in tamoxifen-resistant breast cancer cells","volume":"24","author":"Lv","year":"2022","journal-title":"Mol Ther Oncolytics"},{"key":"10.1124\/pharmrev.123.001028_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117366","article-title":"Hydroxychloroquine suppresses lung tumorigenesis via inducing FoxO3a nuclear translocation through STAT3 inactivation","volume":"246","author":"Lyu","year":"2020","journal-title":"Life Sci"},{"key":"10.1124\/pharmrev.123.001028_bib109","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.tplants.2019.09.006","article-title":"CRISPR\/Cas system: recent advances and future prospects for genome editing","volume":"24","author":"Manghwar","year":"2019","journal-title":"Trends Plant Sci"},{"key":"10.1124\/pharmrev.123.001028_bib110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm1310","article-title":"Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics","volume":"5","author":"Maquat","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/pharmrev.123.001028_bib111","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41573-022-00409-3","article-title":"The emerging role of mass spectrometry-based proteomics in drug discovery","volume":"21","author":"Meissner","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pharmrev.123.001028_bib112","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41587-022-01539-0","article-title":"A proteome-wide atlas of drug mechanism of action","volume":"41","author":"Mitchell","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1124\/pharmrev.123.001028_bib113","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350485","article-title":"From simple to complex: protein-based biomarker discovery in tuberculosis","volume":"53","author":"Mousavian","year":"2023","journal-title":"Eur J Immunol"},{"key":"10.1124\/pharmrev.123.001028_bib114","first-page":"93","article-title":"Proteomics\u2014a new way for drug target discovery","volume":"48","author":"M\u00fcllner","year":"1998","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/pharmrev.123.001028_bib115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/genes14020357","article-title":"Nonsense-mediated mRNA decay as a mediator of tumorigenesis","volume":"14","author":"Nagar","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1124\/pharmrev.123.001028_bib116","first-page":"37","article-title":"Clinical potential of ataluren in the treatment of Duchenne muscular dystrophy","volume":"6","author":"Namgoong","year":"2016","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"10.1124\/pharmrev.123.001028_bib117","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4103\/jehp.jehp_298_23","article-title":"Analysis of computational intelligence approaches for predicting disease severity in humans: challenges and research guidelines","volume":"12","author":"Narasimhan","year":"2023","journal-title":"J Educ Health Promot"},{"key":"10.1124\/pharmrev.123.001028_bib118","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2174\/156802662019200701164759","article-title":"Experimental and computational approaches to improve binding affinity in chemical biology and drug discovery","volume":"20","author":"Nayarisseri","year":"2020","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/pharmrev.123.001028_bib119","article-title":"Improved expression and purification of highly active 3 chymotrypsin-like protease from SARS-CoV-2","volume":"215","author":"Nguyen","year":"2023","journal-title":"Protein Expr Purif"},{"key":"10.1124\/pharmrev.123.001028_bib120","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12943-021-01364-0","article-title":"Nonsense-mediated RNA decay and its bipolar function in cancer","volume":"20","author":"Nogueira","year":"2021","journal-title":"Mol Cancer"},{"key":"10.1124\/pharmrev.123.001028_bib121","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/clpt.2013.37","article-title":"A map of Alzheimer's disease-signaling pathways: a hope for drug target discovery","volume":"93","author":"Ogishima","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pharmrev.123.001028_bib122","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/bib\/bbz122","article-title":"An omics perspective on drug target discovery platforms","volume":"21","author":"Paananen","year":"2020","journal-title":"Brief Bioinform"},{"key":"10.1124\/pharmrev.123.001028_bib123","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1021\/acs.jproteome.3c00471","article-title":"NDUFA12 as a functional target of the anticancer compound ertredin in human hepatoma cells as revealed by label-free chemical proteomics","volume":"23","author":"Park","year":"2024","journal-title":"J Proteome Res"},{"key":"10.1124\/pharmrev.123.001028_bib124","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.drudis.2019.06.014","article-title":"Drug repurposing: a promising tool to accelerate the drug discovery process","volume":"24","author":"Parvathaneni","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1124\/pharmrev.123.001028_bib125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature08999","article-title":"Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay","volume":"465","author":"Pastor","year":"2010","journal-title":"Nature"},{"key":"10.1124\/pharmrev.123.001028_bib126","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/bib\/bbaa027","article-title":"Drug repositioning by prediction of drug's anatomical therapeutic chemical code via network-based inference approaches","volume":"22","author":"Peng","year":"2021","journal-title":"Brief Bioinform"},{"key":"10.1124\/pharmrev.123.001028_bib127","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14017","article-title":"A comprehensive AI-driven analysis of large-scale omic datasets reveals novel dual-purpose targets for the treatment of cancer and aging","volume":"22","author":"Pun","year":"2023","journal-title":"Aging Cell"},{"key":"10.1124\/pharmrev.123.001028_bib128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pharmrev.123.001028_bib129","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1101\/sqb.2011.76.010694","article-title":"Metabolomics in drug target discovery","volume":"76","author":"Rabinowitz","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1124\/pharmrev.123.001028_bib130","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood.2019003654","article-title":"Quantitative proteomics reveals specific metabolic features of acute myeloid leukemia stem cells","volume":"136","author":"Raffel","year":"2020","journal-title":"Blood"},{"key":"10.1124\/pharmrev.123.001028_bib131","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1038\/s41467-023-43790-2","article-title":"Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening","volume":"14","author":"Ramos","year":"2023","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.123.001028_bib132","doi-asserted-by":"crossref","DOI":"10.5808\/gi.22065","article-title":"Functional annotation of uncharacterized proteins from Fusobacterium nucleatum: identification of virulence factors","volume":"21","author":"Rauthan","year":"2023","journal-title":"Genomics Inform"},{"key":"10.1124\/pharmrev.123.001028_bib133","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1273994","article-title":"Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modeling","volume":"14","author":"Ravichandran","year":"2023","journal-title":"Front Genet"},{"key":"10.1124\/pharmrev.123.001028_bib134","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-1-0716-0159-4_14","article-title":"Metabolic network reconstructions to predict drug targets and off-target effects","volume":"2088","author":"Rawls","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pharmrev.123.001028_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114798","article-title":"Drug affinity responsive target stability (DARTS) accelerated small molecules target discovery: principles and application","volume":"194","author":"Ren","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.123.001028_bib136","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/bib\/bby061","article-title":"Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases","volume":"20","author":"Rifaioglu","year":"2019","journal-title":"Brief Bioinform"},{"key":"10.1124\/pharmrev.123.001028_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2020.02.007","article-title":"Genome-scale CRISPR screening in human intestinal organoids identifies drivers of TGF-\u03b2 resistance","volume":"26","author":"Ringel","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1124\/pharmrev.123.001028_bib138","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cbpa.2019.10.003","article-title":"Machine learning for target discovery in drug development","volume":"56","author":"Rodrigues","year":"2020","journal-title":"Curr Opin Chem Biol"},{"key":"10.1124\/pharmrev.123.001028_bib139","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s42003-023-04700-w","article-title":"A multi-omics integrative analysis based on CRISPR screens re-defines the pluripotency regulatory network in ESCs","volume":"6","author":"Ruan","year":"2023","journal-title":"Commun Biol"},{"key":"10.1124\/pharmrev.123.001028_bib140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147215","article-title":"When quality beats quantity: decision theory, drug discovery, and the reproducibility crisis","volume":"11","author":"Scannell","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/pharmrev.123.001028_bib141","doi-asserted-by":"crossref","first-page":"127","DOI":"10.12688\/f1000research.50850.3","article-title":"Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches","volume":"10","author":"Selvaraj","year":"2021","journal-title":"F1000Res"},{"key":"10.1124\/pharmrev.123.001028_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2021.08.034","article-title":"NSD2 dimethylation at H3K36 promotes lung adenocarcinoma pathogenesis","volume":"81","author":"Sengupta","year":"2021","journal-title":"Mol Cell"},{"key":"10.1124\/pharmrev.123.001028_bib143","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"10.1124\/pharmrev.123.001028_bib144","doi-asserted-by":"crossref","first-page":"875","DOI":"10.7150\/thno.66420","article-title":"5-Aza-2\u2032-deoxycytidine potentiates anti-tumor immunity in colorectal peritoneal metastasis by modulating ABC A9-mediated cholesterol accumulation in macrophages","volume":"12","author":"Shi","year":"2022","journal-title":"Theranostics"},{"key":"10.1124\/pharmrev.123.001028_bib145","doi-asserted-by":"crossref","first-page":"22390","DOI":"10.1073\/pnas.2008724117","article-title":"PIWIL1 promotes gastric cancer via a piRNA-independent mechanism","volume":"117","author":"Shi","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.123.001028_bib146","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1517\/17425255.4.3.273","article-title":"Target specificity and off-target effects as determinants of cancer drug efficacy","volume":"4","author":"Shoshan","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/pharmrev.123.001028_bib147","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.coph.2013.04.011","article-title":"Single-cell transcriptomics for drug target discovery","volume":"13","author":"Spaethling","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/pharmrev.123.001028_bib148","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nm.4219","article-title":"Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors","volume":"23","author":"Steinhart","year":"2017","journal-title":"Nat Med"},{"key":"10.1124\/pharmrev.123.001028_bib149","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.tig.2020.11.002","article-title":"To NMD or not to NMD: nonsense-mediated mrna decay in cancer and other genetic diseases","volume":"37","author":"Supek","year":"2021","journal-title":"Trends Genet"},{"key":"10.1124\/pharmrev.123.001028_bib150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5214\/ans.0972.7531.1118109","article-title":"Zinc finger nucleases: a new era for transgenic animals","volume":"18","author":"Swarthout","year":"2011","journal-title":"Ann Neurosci"},{"key":"10.1124\/pharmrev.123.001028_bib151","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41568-022-00481-2","article-title":"Nonsense-mediated RNA decay: an emerging modulator of malignancy","volume":"22","author":"Tan","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/pharmrev.123.001028_bib152","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10822-021-00404-7","article-title":"Binding affinity prediction for binary drug-target interactions using semi-supervised transfer learning","volume":"35","author":"Tanoori","year":"2021","journal-title":"J Comput Aided Mol Des"},{"key":"10.1124\/pharmrev.123.001028_bib153","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63326","article-title":"The mTORC1-mediated activation of ATF4 promotes protein and glutathione synthesis downstream of growth signals","volume":"10","author":"Torrence","year":"2021","journal-title":"Elife"},{"key":"10.1124\/pharmrev.123.001028_bib154","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s43018-024-00742-z","article-title":"Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cells","volume":"5","author":"Ubhi","year":"2024","journal-title":"Nat Cancer"},{"key":"10.1124\/pharmrev.123.001028_bib155","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1186\/s12885-022-09736-5","article-title":"Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer","volume":"22","author":"Ucaryilmaz Metin","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1124\/pharmrev.123.001028_bib156","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2121609119","article-title":"Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegeneration","volume":"119","author":"Vest","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/pharmrev.123.001028_bib157","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.aca.2017.01.059","article-title":"A review on mass spectrometry-based quantitative proteomics: Targeted and data independent acquisition","volume":"964","author":"Vidova","year":"2017","journal-title":"Anal Chim Acta"},{"key":"10.1124\/pharmrev.123.001028_bib158","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-26276-x","article-title":"The module triad: a novel network biology approach to utilize patients' multi-omics data for target discovery in ulcerative colitis","volume":"12","author":"Voitalov","year":"2022","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.123.001028_bib159","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1158\/2643-3230.BCD-22-0086","article-title":"In vivo screening unveils pervasive RNA-binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target","volume":"4","author":"Vujovic","year":"2023","journal-title":"Blood Cancer Discov"},{"key":"10.1124\/pharmrev.123.001028_bib160","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41419-020-2595-9","article-title":"Holliday junction recognition protein promotes pancreatic cancer growth and metastasis via modulation of the MDM2\/p53 signaling","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1124\/pharmrev.123.001028_bib161","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41392-022-00959-3","article-title":"Gefitinib and fostamatinib target EGFR and SYK to attenuate silicosis: a multi-omics study with drug exploration","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1124\/pharmrev.123.001028_bib162","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jare.2020.10.005","article-title":"Calenduloside E suppresses calcium overload by promoting the interaction between L-type calcium channels and Bcl2-associated athanogene 3 to alleviate myocardial ischemia\/reperfusion injury","volume":"34","author":"Wang","year":"2021","journal-title":"J Adv Res"},{"key":"10.1124\/pharmrev.123.001028_bib163","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s12032-022-01727-7","article-title":"Message in hand: the application of CRISPRi, RNAi, and LncRNA in adenocarcinoma","volume":"39","author":"Wang","year":"2022","journal-title":"Med Oncol"},{"key":"10.1124\/pharmrev.123.001028_bib164","doi-asserted-by":"crossref","first-page":"13237","DOI":"10.1039\/D0CC05721E","article-title":"Single-cell infrared phenomics: phenotypic screening with infrared microspectroscopy","volume":"56","author":"Wang","year":"2020","journal-title":"Chem Commun (Camb)"},{"key":"10.1124\/pharmrev.123.001028_bib165","doi-asserted-by":"crossref","DOI":"10.1002\/INMD.20220005","article-title":"Dynamic responsiveness of self-assembling peptide-based nano-drug systems","volume":"1","author":"Wang","year":"2023","journal-title":"Interdisciplinary Medicine"},{"key":"10.1124\/pharmrev.123.001028_bib166","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1124\/pharmrev.123.001028_bib167","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.3390\/biomedicines10112948","article-title":"PTC124 rescues nonsense mutation of two tumor suppressor genes NOTCH1 and FAT1 to repress HNSCC cell proliferation","volume":"10","author":"Wu","year":"2022","journal-title":"Biomedicines"},{"key":"10.1124\/pharmrev.123.001028_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2021.102101","article-title":"Network biology bridges the gaps between quantitative genetics and multi-omics to map complex diseases","volume":"66","author":"Wu","year":"2022","journal-title":"Curr Opin Chem Biol"},{"key":"10.1124\/pharmrev.123.001028_bib169","article-title":"A transcriptomics-guided drug target discovery strategy identifies receptor ligands for lung regeneration","volume":"8","author":"Wu","year":"2022","journal-title":"Sci Adv"},{"key":"10.1124\/pharmrev.123.001028_bib170","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1016\/j.apsb.2021.03.021","article-title":"Protocatechuic aldehyde protects cardiomycoytes against ischemic injury via regulation of nuclear pyruvate kinase M2","volume":"11","author":"Wu","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/pharmrev.123.001028_bib171","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3389\/fphar.2018.01134","article-title":"Network-based methods for prediction of drug-target interactions","volume":"9","author":"Wu","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.123.001028_bib172","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jpha.2020.02.002","article-title":"Drug target discovery by magnetic nanoparticles coupled mass spectrometry","volume":"11","author":"Xia","year":"2021","journal-title":"J Pharm Anal"},{"key":"10.1124\/pharmrev.123.001028_bib173","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41392-024-01758-8","article-title":"Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1","volume":"9","author":"Xie","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1124\/pharmrev.123.001028_bib174","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41587-021-00944-1","article-title":"Genome-wide interrogation of gene functions through base editor screens empowered by barcoded sgRNAs","volume":"39","author":"Xu","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1124\/pharmrev.123.001028_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104587","article-title":"Genome-wide CRISPR\/Cas9 screening identifies a targetable MEST-PURA interaction in cancer metastasis","volume":"92","author":"Xu","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1124\/pharmrev.123.001028_bib176","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1109\/TCBB.2021.3066813","article-title":"Inferring drug-target interactions based on random walk and convolutional neural network","volume":"19","author":"Xu","year":"2022","journal-title":"IEEE\/ACM Trans Comput Biol and Bioinf"},{"key":"10.1124\/pharmrev.123.001028_bib177","article-title":"From multi-omics data to the cancer druggable gene discovery: a novel machine learning-based approach","volume":"24","author":"Yang","year":"2023","journal-title":"Brief Bioinform"},{"key":"10.1124\/pharmrev.123.001028_bib178","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.928328","article-title":"A multi-omic approach reveals utility of CD45 expression in prognosis and novel target discovery","volume":"13","author":"Ye","year":"2022","journal-title":"Front Genet"},{"key":"10.1124\/pharmrev.123.001028_bib179","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-022-00994-0","article-title":"Artificial intelligence in cancer target identification and drug discovery","volume":"7","author":"You","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1124\/pharmrev.123.001028_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114864","article-title":"Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K\/AKT\/mTOR and MAPK signaling pathways","volume":"195","author":"Yu","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pharmrev.123.001028_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105549","article-title":"Exploring the possible molecular targeting mechanism of Saussurea involucrata in the treatment of COVID-19 based on bioinformatics and network pharmacology","volume":"146","author":"Zhang","year":"2022","journal-title":"Comput Biol Med"},{"key":"10.1124\/pharmrev.123.001028_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111833","article-title":"Application of omics- and multi-omics-based techniques for natural product target discovery","volume":"141","author":"Zhang","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1124\/pharmrev.123.001028_bib183","article-title":"Icariin: a potential molecule for treatment of knee osteoarthritis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.123.001028_bib184","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2174\/1389200219666180821094047","article-title":"Recent advances in the machine learning-based drug-target interaction prediction","volume":"20","author":"Zhang","year":"2019","journal-title":"Curr Drug Metab"},{"key":"10.1124\/pharmrev.123.001028_bib185","article-title":"Investigation of anti-depression effects and potential mechanisms of the ethyl acetate extract of Cynomorium songaricum Rupr. through the integration of in vivo experiments, LC-MS\/MS chemical analysis, and a systems biology approach","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1124\/pharmrev.123.001028_bib186","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41419-021-04221-6","article-title":"Src acts as the target of matrine to inhibit the proliferation of cancer cells by regulating phosphorylation signaling pathways","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1124\/pharmrev.123.001028_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107136","article-title":"A survey of drug-target interaction and affinity prediction methods via graph neural networks","volume":"163","author":"Zhang","year":"2023","journal-title":"Comput Biol Med"},{"key":"10.1124\/pharmrev.123.001028_bib188","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.compbiomed.2019.01.009","article-title":"Application of supervised machine learning algorithms in the classification of sagittal gait patterns of cerebral palsy children with spastic diplegia","volume":"106","author":"Zhang","year":"2019","journal-title":"Comput Biol Med"},{"key":"10.1124\/pharmrev.123.001028_bib189","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/14786419.2019.1582047","article-title":"Network pharmacology uncovers anti-cancer activity of vibsane-type diterpenes from Viburnum odoratissimum","volume":"35","author":"Zhang","year":"2021","journal-title":"Nat Prod Res"},{"key":"10.1124\/pharmrev.123.001028_bib190","article-title":"Effect of COP1 in promoting the tumorigenesis of gastric cancer by down-regulation of CDH18 via PI3K\/AKT signal pathway","volume":"2023","author":"Zhao","year":"2023","journal-title":"Anal Cell Pathol (Amst)"},{"key":"10.1124\/pharmrev.123.001028_bib191","doi-asserted-by":"crossref","DOI":"10.1002\/INMD.20230004","article-title":"From classic medicinal chemistry to state-of-the-art interdisciplinary medicine: recent advances in proteolysis-targeting chimeras technology","volume":"1","author":"Zhao","year":"2023","journal-title":"Interdisciplinary Medicine"},{"key":"10.1124\/pharmrev.123.001028_bib192","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12964-021-00800-4","article-title":"Cytoplasmic eIF6 promotes OSCC malignant behavior through AKT pathway","volume":"19","author":"Zhao","year":"2021","journal-title":"Cell Commun Signal"},{"key":"10.1124\/pharmrev.123.001028_bib193","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1101\/gr.147546.112","article-title":"A broadly applicable high-throughput screening strategy identifies new regulators of Dlg4 (Psd-95) alternative splicing","volume":"23","author":"Zheng","year":"2013","journal-title":"Genome Res"},{"key":"10.1124\/pharmrev.123.001028_bib194","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1080\/15548627.2020.1757955","article-title":"Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway","volume":"17","author":"Zheng","year":"2021","journal-title":"Autophagy"},{"key":"10.1124\/pharmrev.123.001028_bib195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jare.2021.06.004","article-title":"Osteosarcoma cell proliferation suppression via SHP-2-mediated inactivation of the JAK\/STAT3 pathway by tubocapsenolide A","volume":"34","author":"Zhu","year":"2021","journal-title":"J Adv Res"},{"key":"10.1124\/pharmrev.123.001028_bib196","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/alz.12653","article-title":"Tau-induced deficits in nonsense-mediated mRNA decay contribute to neurodegeneration","volume":"19","author":"Zuniga","year":"2023","journal-title":"Alzheimers Dement"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724016405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724016405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pharmrev.123.001028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T06:10:19Z","timestamp":1739859019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724016405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":196,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0031699724016405"],"URL":"https:\/\/doi.org\/10.1124\/pharmrev.123.001028","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Art of Finding the Right Drug Target: Emerging Methods and Strategies","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pharmrev.123.001028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}